Claims
- 1. A carrier-bonded biologically active substance comprising a biologically active substance bound directly or through a spacer to a polymer which consists substantially of a base polymer which comprises units (II) or a mixture of units (I) and (II) containing more than 50% by weight of units (II) based on said mixture, said units (I) and (II) having the following structural formulas ##STR4## in which R.sub.1 and R.sub.2 are hydrogen or a monovalent hydrocarbon radical with up to 8 carbon atoms, which polymer also contains convalently bonded units which are derived from at least one compound of formula (III) ##STR5## in an amount of greater than 0% and up to 30% by weight, based on the base polymer, and which are grafted onto the base polymer in which:
- R.sub.3 is a hydrocarbon radical with 4 to 30 carbon atoms;
- X is a member selected from the group consisting of --O--, COO-- and mixture thereof;
- R.sub.4 and R.sub.5 are hydrogen or a monovalent hydrocarbon radical with 1 to 8 carbon atoms, with the proviso that at least one of the radicals R.sub.4 and R.sub.5 is hydrogen;
- m is an integer from 1 to 40; and
- n is an integer from 1 to 4.
- 2. The carrier-bonded biologically active substance as claimed in claim 1, wherein the biologically active substance is an enzyme, vitamin, hormone, effector or antibiotic.
- 3. The carrier-bonded substance as claimed in claim 1, wherein the polymer is in the form of predominantly spherical particles with an average particle size of from 20 to 800 .mu.m.
- 4. A process for the preparation of a carrier-bonded biologically active substance which comprises a polymer consisting substantially of a base polymer having units (II) or a mixture of units (I) and (II) containing more than 50% by weight of units (II) based on said mixture, said units (I) and (II) having the following structural formulas ##STR6## in which R.sub.1 and R.sub.2 are hydrogen or a monovalent hydrocarbon radical with up to 8 carbon atoms, which polymer also contains units which are derived from at least one compound of formula (III) ##STR7## in an amount of greater than 0% and up to 30% by weight, based on the base polymer, which are grafted onto the base polymer in which:
- R.sub.3 is a hydrocarbon radical with 4 to 30 carbon atoms;
- X is a member selected from the group consisting of --O--, COO-- and mixture thereof;
- R.sub.4 and R.sub.5 are hydrogen or a monovalent hydrocarbon radical with 1 to 8 carbon atoms, with the proviso that at least one of the radicals R.sub.4 and R.sub.5 is hydrogen;
- m is an integer from 1 to 40; and
- n is an integer from 1 to 4,
- which process comprises polymerizing a compound of the formula (IV) ##STR8## in which R.sub.1 and R.sub.2 are as defined above, in a liquid dispersant in the presence of a free radical initiator, a dispersion stabilizer, and at least one compound of the formula (III), in which R.sub.3, R.sub.4, R.sub.5, X, m and n are as defined above, said dispersion stabilizer being a copolymer of maleic anhydride and at least one comonomer component selected from the group consisting of a vinyl alkyl ether, a vinyl ester and a long-chain alphaolefin to obtain a graft polymerization polymer product containing units (I), and hydrolyzing the majority of the units (I) to obtain units (II) followed by contacting the resultant hydrolyzed polymer product
- with a biologically active substance to obtain said carrier-bonded biologically active substance.
- 5. The process as claimed in claim 4, wherein said vinyl alkyl ether has 6 to 30 carbon atoms in the alkyl radical, said vinyl ester has 6 to 30 carbon atoms in the acyl group, and said long-chain alpha-olefin has 8 to 30 carbon atoms.
- 6. The process as claimed in claim 4, wherein the maleic anhydride and comonomers are in a ratio of about 1:1, the dispersion stabilizer is used in an amount of 0.001 to 10% by weight based on the total amount of monomers, and the vinyl alkyl ether is vinyl stearyl ether and the long-chain alpha-olefin is octadec-1-ene.
- 7. The process as claimed in claim 4, wherein the compound of formula (III) is an oxyethylated alcohol containing a monohydric primary alcohol and an alkyl radical with 4 to 30 carbon atoms, an oxyethylated carboxylic acid containing a monobasic primary carboxylic acid and an alkyl radical with 4 to 30 carbon atoms, or a mixture of both, in an amount of 1 to 30% by weight based on the total amount of monomers.
- 8. The process as claimed in claim 4, wherein the liquid dispersant is a hydrocarbon with 6 to 20 carbon atoms or a light liquid paraffin.
- 9. The process as claimed in claim 4, wherein said hydrolyzing converts at least 95% by weight of the units (I), based on the amount of units (I) and (II), into units (II).
- 10. The carrier-bonded biologically active substance as claimed in claim 1, wherein the biologically active substance is an antigen or antibody.
- 11. The carrier-bonded biologically active substance as claimed in claim 1, wherein the biologically activity substance is an activator or inhibitor.
- 12. The carrier-bonded biologically active substance as claimed in claim 1, wherein the biologically active substance is a protein or polypeptide fragment.
- 13. The process of claim 4 wherein polymerizing of the compound of formula (IV) is in the presence of small amounts of other monomers copolymerizable with the compound.
- 14. The process of claim 4, wherein the hydrolyzed polymer product is contacted with a spacer before contacting with said biologically active substance.
Priority Claims (1)
Number |
Date |
Country |
Kind |
3413904 |
Apr 1984 |
DEX |
|
Parent Case Info
This is a divisional of application Ser. No. 07/001,918, filed Jan. 9, 1987, now U.S. Pat. No. 4,788,278, which was a continuation of application Ser. No. 06/721,913, now abandoned.
US Referenced Citations (8)
Foreign Referenced Citations (5)
Number |
Date |
Country |
667451 |
Sep 1954 |
CAX |
0110281 |
Jun 1984 |
EPX |
2014242 |
Oct 1970 |
DEX |
1009004 |
Sep 1961 |
GBX |
1095485 |
Dec 1967 |
GBX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
1918 |
Jan 1987 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
721913 |
Apr 1985 |
|